Inactive Instrument

Metabolix, Inc. Stock Nasdaq

Equities

US5910188821

Biotechnology & Medical Research

End-of-day quote Nasdaq
- USD - Intraday chart for Metabolix, Inc.
Sales 2024 * 1.2M 1.64M Sales 2025 * 2.6M 3.55M Capitalization 771K 1.05M
Net income 2024 * -9M -12.3M Net income 2025 * -11M -15.03M EV / Sales 2024 * 0.64 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.3 x
P/E ratio 2024 *
-0.11 x
P/E ratio 2025 *
-0.1 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 0%
More Fundamentals * Assessed data
Managers TitleAgeSince
Founder 66 92-05-31
Director of Finance/CFO 68 07-12-31
Chief Tech/Sci/R&D Officer 56 96-12-31
Members of the board TitleAgeSince
Chairman 67 06-09-30
Director/Board Member 61 17-03-01
Founder 66 92-05-31
More insiders
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.
More about the company